Cargando…
Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor Therapy
PURPOSE: Although anti-programmed cell death protein 1 antibody (aPD1) immunotherapy and chemotherapy has made much progress in the treatment of melanoma, the efficacy still needs to be further improved. METHODS: Cancer treatment has been greatly enhanced by the use of nanotechnology. Cancer cell me...
Autores principales: | Zhao, Peiqi, Qiu, Lihua, Zhou, Shiyong, Li, Lanfang, Qian, Zhengzi, Zhang, Huilai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966413/ https://www.ncbi.nlm.nih.gov/pubmed/33737808 http://dx.doi.org/10.2147/IJN.S295565 |
Ejemplares similares
-
Hybrid Membrane Nanovaccines Combined with Immune Checkpoint Blockade to Enhance Cancer Immunotherapy
por: Zhao, Peiqi, et al.
Publicado: (2022) -
A modified prognostic model in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
por: Zhao, Peiqi, et al.
Publicado: (2021) -
Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer
por: Zhao, Peiqi, et al.
Publicado: (2021) -
Mesoporous Silica Nanoparticles as Theranostic Antitumoral Nanomedicines
por: Baeza, Alejandro, et al.
Publicado: (2020) -
Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency
por: Kong, Miao, et al.
Publicado: (2017)